On May 26, the DOJ ended a False Claims Act case with a $23 million settlement. The case, brought by whistleblowers against a pharmacy goods provider (company), involved alleged fraudulent Medicaid claims and kickbacks to pharmacies that prescribed one of the company’s drugs. The qui tam action, originally filed in 2007, resulted in the company agreeing to pay nearly $13 million to the U.S. within seven business days of the settlement, of which the government will pay the whistleblowers $3.7 million. Additionally, the company will pay over $10 million toward state Medicaid settlements.